Fig. 2From: Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world studyRates of TNFi failure on successive lines of TNFi therapy. APAC, Asia Pacific region; EU5, European Union 5; T&ME, Turkey and Middle EastBack to article page